Author:
Jiang Xiao-Bing,He Dong-Sheng,Mao Zhi-Gang,Fan Xiang,Lei Ni,Hu Bin,Song Bing-Bing,Zhu Yong-Hong,Wang Hai-Jun
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of liege, Belgium. J Clin Endocrinol Metab. 2006;91:4769–75.
2. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273–88.
3. Klibanski A. Clinical practice. Prolactinomas. N Engl J Med. 2010;362:1219–26.
4. dos Santos Silva CM, Barbosa FR, Lima GA, et al. BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Obesity (Silver Spring). 2011;19:800–5.
5. Serri O, Li L, Mamputu JC, et al. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol (Oxf). 2006;64:366–70.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献